Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia

Journal of Laboratory and Clinical Medicine

Volumn 145, Issue 2, 2005, Pages 72-82

  Glueck, Charles J ^a   Aregawi, Dawit ^b   Goldenberg, Naila ^b   Golnik, Karl C ^b   Sieve, Luann ^b   Wang, Ping ^b  

^a Cholesterol Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 8; ESTROGEN; GESTAGEN; LIPOPROTEIN A;

ADULT; ARTICLE; BLOOD CLOTTING; BODY MASS; CEREBROSPINAL FLUID DRAINAGE; CEREBROSPINAL FLUID FLOW; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; GENE MUTATION; HOMOZYGOSITY; HORMONE SUBSTITUTION; HUMAN; INTRACRANIAL HYPERTENSION; OBESITY; OCCLUSIVE CEREBROVASCULAR DISEASE; OVARY POLYCYSTIC DISEASE; PATIENT REFERRAL; POLYMERASE CHAIN REACTION; PREGNANCY; SEROLOGY; THROMBOPHILIA;

EID: 14544283353     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2004.09.011     Document Type: Article

References (65)

1. D.K. Binder, J.C. Horton, M.T. Lawton, M.W. McDermott Idiopathic intracranial hypertension Neurosurgery 54 2004 538 552
2. P.W. Brazis, A.G. Lee Elevated intracranial pressure and pseudotumor cerebri Curr Opin Ophthalmol 9 1998 27 32
3. A. Kesler, Y. Goldhammer, N. Gadoth Do men with pseudomotor cerebri share the same characteristics as women? A retrospective review of 141 cases J Neuroophthalmol 21 2001 15 17
4. S. Bandyopadhyay Pseudotumor cerebri Arch Neurol 58 2001 1699 1701
5. A. Kesler, N. Gadoth Epidemiology of idiopathic intracranial hypertension in Israel J Neuroophthalmol 21 2001 12 14
6. F.J. Duncan, J.J. Corbett, M. Wall The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana Arch Neurol 45 1988 875 877
7. C.O. Maher, J.A. Garrity, F.B. Meyer Refractory idiopathic intracranial hypertension treated with stereotactically planned ventriculoperitoneal shunt placement Neurosurg Focus 10 2001 1 4
8. C. Lueck, G. McIlwaine Interventions for idiopathic intracranial hypertension Cochrane Database Syst Rev 3 2002 CD 003434
9. A. Quattrone, A. Gambardella, A.M. Carbone, R.L. Oliveri, A. Lavano, E.V. De Marco A hypofibrinolytic state in overweight patients with cerebral venous thrombosis and isolated intracranial hypertension J Neurol 246 1999 1086 1089
10. J. Sussman, M. Leach, M. Greaves, R. Malia, G.A. Davies-Jones Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension J Neurol Neurosurg Psychiatry 62 1997 229 233
11. A. Daif, A. Awada, S. al-Rajeh, M. Abduljabbar, A.R. al Tahan, T. Obeid Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia Stroke 26 1995 1193 1195
12. A.G. Munts, P.J. Vangenderen, D.W. Dippel, F. Van Kooten, P.J. Koudstaal Coagulation disorders in young adults with acute cerebral ischaemia J Neurol 245 1998 21 25
13. V. Biousse, A. Ameri, M.G. Bousser Isolated intracranial hypertension as the only sign of cerebral venous thrombosis Neurology 53 1999 1537 1542
14. P.N. Sylaja, A. Moosa, K. Radhakrishnan, S.P. Sankara, K.S. Pradeep Differential diagnosis of patients with intracranial sinus venous thrombosis related isolated intracranial hypertension from those with idiopathic intracranial hypertension J Neurol Sci 215 2003 9 12
15. C.J. Glueck, S. Iyengar, N. Goldenberg, L. Sieve-Smith, P. Wang Idiopathic intracranial hypertension. Associations with coagulation disorders and polycystic-ovary syndrome J Lab Clin Med 142 2003 35 45
16. S. Dunkley, I. Johnston Thrombophilia as a common predisposing factor in pseudotumor cerebri Blood 103 2004 1972 1973
17. H.J. Sugerman, E.J. DeMaria, W.L. Felton III, M. Nakatsuka, A. Sismanis Increased intra- abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri Neurology 49 1997 507 511
18. D.G. Krahalios, H.L. Rekate, M.H. Khayata, P.J. Apostolides Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies Neurology 46 1996 198 202
19. C.J. Glueck, P. Wang, L. Sieve-Smith, R. Fontaine, T. Tracy Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with polycystic ovary syndrome Metabolism 48 1999 511 519
20. C.J. Glueck, P. Wang, R. Fontaine, T. Tracy, L. Sieve-Smith Metformin to restore normal menstrual cycles in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS) J Adolesc Health 29 2001 160 169
21. C.J. Glueck, P. Streicher, P. Wang Treatment of polycystic ovary syndrome with insulin lowering agents Exp Opin Pharmacother 3 2002 1177 1189
22. E.M. Velazquez, S. Mendoza, T. Hamer, F. Sosa, C.J. Glueck Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy Metabolism 43 1994 647 654
23. E.M. Velazquez, S.G. Mendoza, P. Wang, C.J. Glueck Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein (a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome Metabolism 46 1997 454 457
24. S.F. de Bruijn, J. Stam, M.M. Koopman, J.P. Vandenbroucke The Cerebral Venous Sinus Thrombosis Study Group Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in carriers of hereditary prothrombotic conditions BMJ 316 1998 589 592
25. E. Hoibraaten, M.C. Mowinckel, H. de Ronde, R.M. Bertina, P.M. Sandset Hormone replacement therapy and acquired resistance to activated protein C results of a randomized, double-blind, placebo-controlled trial Br J Haematol 115 2001 415 420
26. E. Hoibraaten, E. Qvigstad, T.O. Anderson, M.C. Mowinckel, P.M. Sandset The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism - results from a randomized, double-blind, clinical trial Thromb Haemost 85 2001 775 781
27. C.J. Glueck, M.J. Kupferminc, R.N. Fontaine, P. Wang, B.B. Weksler, A. Eldor Genetic hypofibrinolysis in complicated pregnancies Obstet Gynecol 97 2001 44 48
28. A. la Marca, G. Morgante, M. Palumbo, A. Cianci, F. Petraglia, V. De Leo Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome Fertil Steril 78 2002 1234 1239
29. A. Meyer-Heim, K. Landau, E. Boltshauser Treatment of acne with consequences - pseudotumor cerebri due to hypervitaminosis A Schweiz Rundsch Med Prax 91 2002 23 26
30. L. Green, S. Vinker, H. Amital, T. Amir, Y. Bar-Dayan, Y. Levi Pseudotumor cerebri in systemic lupus erythematosus Semin Arthritis Rheum 25 1995 103 108
31. R. Somech, R. Arav-Boger, A. Assia, Z. Spirer, U. Jurgenson Complications of minocycline therapy for acne vulgaris case reports and review of the literature Pediatr Dermatol 16 1999 469 472
32. A.H. Rogers, G.L. Rogers, D.L. Bremer, M.L. McGregor Pseudotumor cerebri in children receiving recombinant human growth hormone Ophthalmology 106 1999 1186 1189
33. C.J. Glueck, N. Goldenberg, K. Golnik, L. Sieve, P. Wang Idiopathic intracranial hypertension associations with thrombophilia and hypofibrinolysis in men Clin Appl Thromb Hemost 2005 in press.
34. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Rep 19 2003 41 47
35. V.V. Balasa, R. Gruppo, C.J. Glueck, D. Stroop, A. Becker, A. Pillow The relationship of mutations in the methylenetetrahydrofolate reductase, prothrombin, and plasminogen activator inhibitor-1 genes to plasma levels of homocysteine, prothrombin, and plasminogen activator inhibitor-1 levels in children and adults Thromb Haemost 81 1999 739 744
36. C.J. Glueck, R.N. Fontaine, P. Wang Interaction of heritable and estrogen-induced thrombophilia possible pathoetiologies for ischemic optic neuropathy and ischemic stroke Thromb Haemost 85 2001 256 259
37. C.J. Glueck, R.A. Freiberg, R.N. Fontaine, T. Tracy, P. Wang Hypofibrinolysis, thrombophilia, osteonecrosis Clin Orthop 386 2002 19 33
38. C.J. Glueck, H. Bell, L. Vadlamani, A. Gupta, R.N. Fontaine, P. Wang Heritable thrombophilia and hypofibrinolysis Arch Ophthalmol 117 1999 43 49
39. J.T. Brandt, D.A. Triplett, B. Alving, I. Scharrer Criteria for the diagnosis of lupus anticoagulants an update Thromb Haemost 74 1995 1185 1190
40. K.M. Flegal, M.D. Carroll, C.L. Ogden, C.L. Johnson Prevalence and trends in obesity among US adults, 1999-2000 JAMA 288 2002 1723 1727
41. K. Singh, G.C. Chye Adverse effects associated with contraceptive implants incidence, prevention and management Adv Contracept 14 1998 1 13
42. D.K. Wysowski, L. Green Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System Obstet Gynecol 85 1995 538 542
43. E.S. Knochenhauer, T.J. Key, M. Kashar-Miller, W. Waggoner, L.R. Boots, R. Azziz Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States a prospective study J Clin Endocrinol Metab 83 1998 3078 3082
44. C.J. Glueck, P. Wang, N. Goldenberg, L. Sieve-Smith Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin Hum Reprod 17 2002 2858 2864
45. I. Juhan-Vague, M.C. Alessi, P.E. Morange Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity Ann Med 32 suppl 1 2000 78 84
46. T. Hoekstra, J.M. Geleijnse, E.G. Schouten, C. Kluft Plasminogen activator inhibitor-type I its plasma determinants and relation with cardiovascular risk Thromb Haemost 91 2004 861 872
47. L.K. Bowles, J.A. Cooper, D.J. Howarth, G.J. Miller, P.K. MacCallum Associations of haemostatic variables with body mass index a community-based study Blood Coagul Fibrinol 14 2003 569 573
48. H. Uzun, K. Zengin, M. Taskin, S. Aydin, G. Simsek, N. Darieyerli Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric binding Obes Surg 14 2004 659 665
49. M. Abdollahi, M. Cushman, F.R. Rosendaal Obesity risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use Thromb Haemost 89 2003 493 498
50. T. Key, P.N. Appleby, G.K. Reeves, A. Roddam, J.F. Dorgan, C. Longcope Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women J Nat Cancer Inst 95 2003 1218 1226
51. C.J. Glueck, N. Goldenberg, C. Golnick, L. Sieve, P. Wang Idiopathic intracranial hypertension associations with coagulation disorders and polycystic ovary syndrome [abstract] J Invest Med 52 suppl 2 2004 382
52. D.J. Harrington, A. Malefora, V. Schmeleva, S. Kapustin, L. Papayan, M. Blino Genetic variations observed in arterial and venous thromboembolism - relevance for therapy, risk prevention and prognosis Clin Chem Lab Med 43 2003 496 500
53. Y.Z. Zheng, J. Tong, X.P. Do, X.Q. Pu, B.T. Zhou Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population Br J Haematol 109 2000 870 874
54. F. Courturaud, E. Oger, J.H. Abalain, E. Chenu, B. Guias, H.H. Floch Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease Respiration 67 2000 657 661
55. A. Loewenstein, M. Goldstein, A. Winder, M. Lazar, A. Eldor Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation Ophthalmology 106 1999 1817 1820
56. C.J. Glueck, P. Shaw, J.E. Lang, T. Tracy, L. Sieve-Smith, Y. Wang Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients Am J Cardiol 75 1995 132 136
57. R. Marucci, A.A. Liotta, A.P. Cellai, A. Rogolino, A.M. Gori, B. Giusti Increased plasma levels of lipoprotein (a) and the risk of idiopathic and recurrent venous thromboembolism Am J Med 115 2003 601 605
58. J. O'Donnell, A.D. Mumford, R.A. Manning, M. Laffan Elevation of FVIII:C in venous thromboembolism is persistent and independent of the acute phase response Thromb Haemost 83 2002 10 13
59. R.A. Kraaijenhagen, P.S. in't Anker, M.M. Koopman, P.H. Reitsma, M.H. Prins, A. van den Ende High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism Thromb Haemost 83 2000 5 9
60. J. O'Donnell, M. Laffan Elevated plasma factor VIII levels - a novel risk factor for venous thromboembolism Clin Lab 47 2001 1 6
61. J. O'Donnell, E.G. Tuddenham, R. Manning, G. Kemball-Cook, D. Johnson, M. Laffan High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening rose of increased synthesis and relationship to acute phase reaction Thromb Haemost 77 1997 825 828
62. P.W. Kamphuisen, J.J. Houwing-Duistermaat, H.C. van Houwelingen, J.C. Eikenboom, E.M. Bertina, F.R. Rosendaal Familial clustering of factor VIII and von Willebrand factor levels Thromb Haemost 79 1998 323 327
63. P.W. Kamphuisen, R. Lensen, J.J. Houwing-Duistermaat, J.C. Eikenboom, M. Harvey, R.M. Bertina Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia Br J Haematol 109 2000 519 522
64. C.M. Schambeck, K. Hinney, I. Haubitz, B. Mansouri Taleghani, D. Wahler, F. Keller Familial clustering of high factor VIII levels in patients with venous thromboembolism Arterioscler Thromb Vasc Biol 21 2001 289 292
65. D. Ferriman, J. Gallwey Clinical assessment of body hair growth in women J Clin Endocrinol Metab 21 1961 1440 1447